Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
OMER

Omeros

$24.61

1.16 (4.95%)

09:14
08/15/17
08/15
09:14
08/15/17
09:14
Technical Analysis
Technical View: Omeros drops on 3M share Spot Secondary priced at $22.75 »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

OMER

Omeros

$24.61

1.16 (4.95%)

09:07
08/15/17
08/15
09:07
08/15/17
09:07
Syndicate
Omeros 3M share Spot Secondary priced at $22.75 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

Over a week ago
FATE

Fate Therapeutics

$3.09

0.11 (3.69%)

, EXTR

Extreme Networks

$9.32

0.69 (8.00%)

17:41
08/14/17
08/14
17:41
08/14/17
17:41
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Fate…

FATE

Fate Therapeutics

$3.09

0.11 (3.69%)

EXTR

Extreme Networks

$9.32

0.69 (8.00%)

WPRT

Westport

$1.91

0.08 (4.37%)

SYF

Synchrony

$29.64

0.44 (1.51%)

BRK.A

Berkshire Hathaway

$266,369.99

3369.99 (1.28%)

BRK.B

Berkshire Hathaway

$177.29

1.95 (1.11%)

P

Pandora

$8.07

-0.01 (-0.12%)

PLAB

Photronics

$9.85

0.35 (3.68%)

HOLI

Hollysys

$19.01

0.12 (0.64%)

RETA

Reata Pharmaceuticals

$27.44

-0.42 (-1.51%)

OMER

Omeros

$24.61

1.16 (4.95%)

G

Genpact

$29.43

0.11 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 15

    Aug

  • 15

    Aug

  • 16

    Aug

  • 23

    Aug

  • 24

    Aug

  • 29

    Aug

  • 05

    Sep

  • 26

    Sep

  • 15

    Aug

  • 15

    Aug

OMER

Omeros

$24.61

1.16 (4.95%)

16:21
08/14/17
08/14
16:21
08/14/17
16:21
Syndicate
Breaking Syndicate news story on Omeros »

Omeros files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

OMER

Omeros

$24.61

1.16 (4.95%)

16:21
08/14/17
08/14
16:21
08/14/17
16:21
Syndicate
Omeros files to sell 3M shares of common stock »

Cantor Fitzgerald &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

OMER

Omeros

$23.45

-0.11 (-0.47%)

13:02
08/14/17
08/14
13:02
08/14/17
13:02
Hot Stocks
Omeros sees continued improvement in OMS721 treated patients »

Omeros announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

OMER

Omeros

$21.72

-0.43 (-1.94%)

16:07
08/08/17
08/08
16:07
08/08/17
16:07
Earnings
Omeros reports Q2 EPS (33c), consensus (38c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 15

    Aug

OMER

Omeros

$20.50

-0.65 (-3.07%)

11:10
08/04/17
08/04
11:10
08/04/17
11:10
Hot Stocks
Omeros's OMS721 granted orphan drug designation from FDA »

Omeros Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 15

    Aug

OMER

Omeros

$20.50

-0.65 (-3.07%)

07:44
08/04/17
08/04
07:44
08/04/17
07:44
Hot Stocks
Omeros treatment of immunoglobulin A nephropathy granted FDA orphan status »

Omeros' treatment of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 15

    Aug

Over a month ago
OMER

Omeros

$19.11

-0.41 (-2.10%)

14:45
07/10/17
07/10
14:45
07/10/17
14:45
Options
Omeros call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.